Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience.
Eşkazan AE, Özmen D, Öztaş M, Bektaş F, Bayraktar EA, Sadri S, Keskin D, Özgür Yurttaş N, Elverdi T, Salihoğlu A, Ar MC, Öngören Ş, Başlar Z, Aydın Y, Soysal T. Eşkazan AE, et al. Among authors: ozmen d. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):549-557. doi: 10.1016/j.clml.2021.04.005. Epub 2021 Apr 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34052176
Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis.
Küçükyurt S, Kelezoğlu A, Elverdi T, Özmen D, Ar MC, Eşkazan AE. Küçükyurt S, et al. Among authors: ozmen d. Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):275-277. doi: 10.1016/j.htct.2021.04.007. Epub 2021 Jun 16. Hematol Transfus Cell Ther. 2023. PMID: 34210618 Free PMC article. No abstract available.
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.
Narlı Özdemir Z, İpek Y, Patır P, Ermiş G, Çiftçiler R, Özmen D, Baysal M, Gürsoy V, Yıldızhan E, Güven S, Ercan T, Elibol T, Mersin S, Genç E, Davulcu EA, Karakuş V, Erkut N, Güneş G, Diz Küçükkaya R, Eşkazan AE. Narlı Özdemir Z, et al. Among authors: ozmen d. Turk J Haematol. 2024 Mar 1;41(1):26-36. doi: 10.4274/tjh.galenos.2024.2023.0430. Turk J Haematol. 2024. PMID: 38433449 Free PMC article.
Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study.
Çiftçiler R, Selim C, Cömert M, Zengin H, İpek Y, Gürsoy V, Yıldızhan E, Yıldız A, Yaman S, Elibol T, Güven S, Arslan Davulcu E, Özmen D, Tekinalp A, Narlı Özdemir Z, Baysal M, Mersin S, Güven Z, Pınar İE, Çelik S, Eşkazan AE. Çiftçiler R, et al. Among authors: ozmen d. J Oncol Pharm Pract. 2024 Sep 2:10781552241280615. doi: 10.1177/10781552241280615. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 39221456
Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology.
Baysal M, Aksoy E, Bedir KH, Özmen D, Patır P, Demirci U, Yaman S, Özdemir ZN, Gürsoy V, Yıldızhan E, Güven S, Çiftçiler R, İpek Y, Pınar İE, Genç EE, Mersin S, Uğur MC, Karabulut ZT, Hindilerden F, Hindilerden İY, Gulturk E, Cömert M, Karakuş V, Erkut N, Yıldız A, Ümit EG, Demir AM, Küçükkaya RD, Eşkazan AE. Baysal M, et al. Among authors: ozmen d. J Thromb Thrombolysis. 2024 Nov 11. doi: 10.1007/s11239-024-03043-5. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 39527392
70 results